PL369449A1 - Solwaty chlorowodorku lerkanidypiny i nowe krystaliczne postacie chlorowodorku lerkanidypiny - Google Patents

Solwaty chlorowodorku lerkanidypiny i nowe krystaliczne postacie chlorowodorku lerkanidypiny

Info

Publication number: PL369449A1
Authority: PL; Poland
Prior art keywords: lercanidipine hydrochloride; solvates; crystalline forms; new crystalline; lercanidipine
Prior art date: 2001-08-06

Application number

PL02369449A

Other languages

English (en)

Inventor

Amedeo Leonardi

Iasi Gianluca De

Fausto Bonifacio

Original Assignee

Recordati Ireland Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-06

Filing date

2002-08-05

Publication date

2005-04-18

2002-08-05 Application filed by Recordati Ireland Limited filed Critical Recordati Ireland Limited

2005-04-18 Publication of PL369449A1 publication Critical patent/PL369449A1/pl

Links

WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 title abstract 5
229960002162 lercanidipine hydrochloride Drugs 0.000 title abstract 5
239000012453 solvate Substances 0.000 title abstract 3
239000013543 active substance Substances 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000007614 solvation Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL02369449A 2001-08-06 2002-08-05 Solwaty chlorowodorku lerkanidypiny i nowe krystaliczne postacie chlorowodorku lerkanidypiny PL369449A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2001MI001727A ITMI20011727A1 (it)	2001-08-06	2001-08-06	Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi

Publications (1)

Publication Number	Publication Date
PL369449A1 true PL369449A1 (pl)	2005-04-18

Family

ID=11448246

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02369449A PL369449A1 (pl)	2001-08-06	2002-08-05	Solwaty chlorowodorku lerkanidypiny i nowe krystaliczne postacie chlorowodorku lerkanidypiny

Country Status (21)

Country	Link
EP (1)	EP1423367B1 (pl)
JP (1)	JP2005502648A (pl)
KR (1)	KR100912664B1 (pl)
CN (1)	CN100494175C (pl)
AR (1)	AR037230A1 (pl)
AT (1)	ATE294162T1 (pl)
AU (1)	AU2002331390B2 (pl)
BR (1)	BR0211738A (pl)
DE (1)	DE60203919D1 (pl)
EA (1)	EA200400279A1 (pl)
ES (1)	ES2209684T1 (pl)
HR (1)	HRP20040157A2 (pl)
HU (1)	HUP0401161A3 (pl)
IL (2)	IL153916A0 (pl)
IT (1)	ITMI20011727A1 (pl)
MX (1)	MXPA04001073A (pl)
NO (1)	NO20040479L (pl)
PE (1)	PE20030350A1 (pl)
PL (1)	PL369449A1 (pl)
UY (1)	UY27409A1 (pl)
WO (1)	WO2003014085A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100651212B1 (ko)	2004-10-27	2006-12-01	제일약품주식회사	무정형 레르카니디핀의 제조방법
AR052918A1 (es)	2005-02-25	2007-04-11	Recordati Ireland Ltd	Clorhidrato de lercanidipina amorfo
EP1940790B1 (en)	2005-09-16	2015-09-02	Glenmark Pharmaceuticals Limited	Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
US20100104649A1 (en) *	2007-03-05	2010-04-29	Actavis Group Ptc Ehf	Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate
WO2008136394A1 (ja) *	2007-04-27	2008-11-13	Ajinomoto Co., Inc.	ラクタム化合物の製造方法及びその製造中間体
SI2585051T2 (sl)	2010-06-23	2020-07-31	Krka, D.D., Novo Mesto	Farmacevtske oralne odmerne oblike,ki obsegajo lerkanidipin in enalapril in njune farmacevtsko sprejemljive soli
WO2012085249A2 (en)	2010-12-24	2012-06-28	Krka, D.D., Novo Mesto	Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8403866D0 (en) *	1984-02-14	1984-03-21	Recordati Chem Pharm	Diphenylalkylaminoalkyl esters
US5767136A (en)	1995-05-12	1998-06-16	Recordati, S.A. Chemical And Pharmaceutical Company	1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls

2001
- 2001-08-06 IT IT2001MI001727A patent/ITMI20011727A1/it unknown
2002
- 2002-08-02 AR ARP020102957A patent/AR037230A1/es not_active Application Discontinuation
- 2002-08-05 KR KR1020047001791A patent/KR100912664B1/ko not_active Expired - Fee Related
- 2002-08-05 EP EP02767318A patent/EP1423367B1/en not_active Expired - Lifetime
- 2002-08-05 EA EA200400279A patent/EA200400279A1/ru unknown
- 2002-08-05 AT AT02767318T patent/ATE294162T1/de not_active IP Right Cessation
- 2002-08-05 WO PCT/EP2002/008700 patent/WO2003014085A1/en not_active Ceased
- 2002-08-05 HU HU0401161A patent/HUP0401161A3/hu unknown
- 2002-08-05 IL IL15391602A patent/IL153916A0/xx unknown
- 2002-08-05 DE DE60203919T patent/DE60203919D1/de not_active Expired - Lifetime
- 2002-08-05 MX MXPA04001073A patent/MXPA04001073A/es not_active Application Discontinuation
- 2002-08-05 CN CNB028155114A patent/CN100494175C/zh not_active Expired - Fee Related
- 2002-08-05 AU AU2002331390A patent/AU2002331390B2/en not_active Ceased
- 2002-08-05 BR BR0211738-0A patent/BR0211738A/pt not_active IP Right Cessation
- 2002-08-05 HR HR20040157A patent/HRP20040157A2/hr not_active Application Discontinuation
- 2002-08-05 JP JP2003519035A patent/JP2005502648A/ja active Pending
- 2002-08-05 PL PL02369449A patent/PL369449A1/pl unknown
- 2002-08-05 ES ES02767318T patent/ES2209684T1/es active Pending
- 2002-08-06 UY UY27409A patent/UY27409A1/es not_active Application Discontinuation
- 2002-08-06 PE PE2002000716A patent/PE20030350A1/es not_active Application Discontinuation
2003
- 2003-01-13 IL IL153916A patent/IL153916A/en unknown
2004
- 2004-02-03 NO NO20040479A patent/NO20040479L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ITMI20011727A1 (it)	2003-02-06
EP1423367A1 (en)	2004-06-02
ITMI20011727A0 (it)	2001-08-06
AR037230A1 (es)	2004-11-03
KR100912664B1 (ko)	2009-08-17
JP2005502648A (ja)	2005-01-27
KR20040030932A (ko)	2004-04-09
HRP20040157A2 (en)	2004-08-31
ATE294162T1 (de)	2005-05-15
NO20040479L (no)	2004-02-03
EP1423367B1 (en)	2005-04-27
IL153916A (en)	2008-07-08
EA200400279A1 (ru)	2004-06-24
DE60203919D1 (de)	2005-06-02
HUP0401161A3 (en)	2009-04-28
CN100494175C (zh)	2009-06-03
CN1538958A (zh)	2004-10-20
HUP0401161A2 (hu)	2004-09-28
WO2003014085A1 (en)	2003-02-20
MXPA04001073A (es)	2005-02-17
BR0211738A (pt)	2004-09-28
AU2002331390B2 (en)	2008-06-05
PE20030350A1 (es)	2003-06-06
UY27409A1 (es)	2003-03-31
ES2209684T1 (es)	2004-07-01
IL153916A0 (en)	2003-07-31

Publication	Publication Date	Title
NO20042739L (no)	2004-07-23	Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
EP2492264A3 (en)	2012-12-19	Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
AU2002352986A1 (en)	2003-06-23	Compositions containing 1,3-dicarbonyl chelating agents for stripping residues from semiconductors
WO2004074244A3 (en)	2004-11-11	Pyrimidine compounds
WO2004004657A3 (en)	2004-11-04	Hiv integrase inhibitors
WO2005011592A3 (en)	2005-06-16	Substituted indazole-o-glucosides
MY145074A (en)	2011-12-15	Thiazolidin-4-one derivatives
WO2003024955A3 (en)	2003-08-14	Small molecule inhibitors of caspases
NO20033732L (no)	2003-10-22	N-substituerte ikke-aryl-heterosykliske NMDA/NR2B-antagonister, og farmasoytiske preparater som omfatter slike forbindelser.
WO2001098236A3 (en)	2002-03-28	7-phenyl-substituted tetracycline compounds
IL162118A0 (en)	2005-11-20	Pharmaceutical compositions containing an orally active taxane derivative
WO2003095455A3 (en)	2003-12-24	Substituted pyrazolopyrimidines
WO2004014893A3 (en)	2004-04-08	Antimicrobial aza-bicyclic derivates, their compositions and uses
IL158485A0 (en)	2004-05-12	Spiropyrazole compounds
NO20024614L (no)	2002-11-26	N-heterosykliske derivater som NOS-hemmere
AP1766A (en)	2007-08-10	Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
CL2004001085A1 (es)	2005-06-03	Compuestos derivados de quinolil propil piperidina, procedimiento de preparacion; compuesto intermediario; composicion farmaceutica, utiles como agentes microbianos.
AP2002002616A0 (en)	2002-09-30	Antidibetic agents
WO2003053971A8 (en)	2004-01-29	Pyridoquinoxaline antivirals
NO20054787L (no)	2005-11-14	Indenderivater som farmasotiske midler
WO2005035537A3 (en)	2005-06-09	Substituted tricyclic heterocycles and their uses
TWI256304B (en)	2006-06-11	Pharmaceutical compositions based on azetidine derivatives
PL369449A1 (pl)	2005-04-18	Solwaty chlorowodorku lerkanidypiny i nowe krystaliczne postacie chlorowodorku lerkanidypiny
WO2001004116A3 (en)	2001-08-23	Neurotrophic pyrrolidines and piperidines, and related compositions containing them
WO2005065047A3 (en)	2006-04-27	Stable oral composition containing desloratadine